Company / Free Cash Flow
Veracyte, Inc. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$126.6M
FY2025
5-year range
-$37.0M / $126.6M
FY2021-FY2025
Trend
+98.5%
vs FY2024
Sector context
#78 of 151
Health Care
What the data says
At $127M, Veracyte, Inc.'s free cash flow ranks #78 of 151 in the Health Care sector. Free Cash Flow has increased for 4 consecutive years, from -$37M in FY2021 to $127M in FY2025.
Based on SEC 10-K filings.
$127M in FY2025.
Improved from $34M to $127M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#78 of 151 in Health CareTop 52% of 151This company $126.6M Sector average $779.8M
▼
-83.8% below sector average
Key checks
Key Insights
- Veracyte, Inc.'s free cash flow has grown for 4 consecutive years.
- In FY2025, free cash flow increased 98.5% year-over-year.
- Ranks #78 out of 151 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $126.6M | +98.5% |
| FY2024 | $63.8M | +86.2% |
| FY2023 | $34.3M | +3478.8% |
| FY2022 | -$1.0M | +97.3% |
| FY2021 | -$37.0M | -140.3% |
| FY2020 | -$15.4M | -157.1% |
| FY2019 | -$6.0M | +61.1% |
| FY2018 | -$15.4M | +53.5% |
| FY2017 | -$33.1M | -11.7% |
| FY2016 | -$29.7M | +10.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026